Dyskinesia
📧 Sign up to get email alerts when something new happens for Dyskinesia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-29Clinical Trial Update: Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy [Phase 3]
Phase 3 trial evaluating valbenazine for dyskinesia associated with cerebral palsy has completed.
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes
A multicenter retrospective survey is being conducted to delineate the molecular and phenotypic spectrum of epilepsy-dyskinesia syndromes in…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Reliability and Validity Study of the Turkish Version of the Parkinson's Disease Dyskinesia Scale (PDYS-26)
A clinical trial evaluating the reliability and validity of the Turkish version of the Parkinson's Disease Dyskinesia Scale (PDYS-26) in ind…
-
CLINICAL_TRIALS research · 2025-08-17Clinical Trial Update: Registry and Natural History of Epilepsy-Dyskinesia Syndromes
A Boston Children's Hospital registry study on the registry and natural history of epilepsy-dyskinesia syndromes, currently recruiting.
-
CLINICAL_TRIALS research · 2025-08-01Clinical Trial Update: Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy [Phase 3]
A Phase 3 clinical trial update for valbenazine evaluating its efficacy, safety, and tolerability for dyskinesia associated with cerebral pa…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: Effects of Music Beat on Motor Function in Individuals At Risk for Psychotic Onset and Schizophrenia Patients [NA]
A completed clinical trial evaluated the effects of music beat on motor function in individuals at risk for psychotic onset and in schizophr…
-
CLINICAL_TRIALS trial_result · 2024-06-17Clinical Trial Update: A Study in Parkinson's Disease in Patients With Moderate to Severe Dyskinesia [Phase 2]
A Phase 2 clinical trial in Parkinson's disease patients with moderate to severe dyskinesia conducted by Contera Pharma has completed.
-
CLINICAL_TRIALS trial_result · 2024-06-17Clinical Trial Update: Study in Parkinson's Disease Patients With Dyskinesia With Combinations of JM-010 and Its Individual Components [Phase 2]
A Phase 2 study evaluating JM-010 and its components in Parkinson disease patients with dyskinesia was terminated.
-
CLINICAL_TRIALS trial_result · 2023-09-08Clinical Trial Update: A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Dyskinesia in Cerebral Palsy in Children and Adolescents [Phase 3]
Phase 3 trial of deutetrabenazine (TEV-50717) for dyskinesia in children and adolescents with cerebral palsy has completed with results post…
-
CLINICAL_TRIALS trial_result · 2022-04-29Clinical Trial Update: Safety and Efficacy of AVP-923 in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease Patients [Phase 2]
Phase 2 clinical trial assessing AVP-923 for levodopa-induced dyskinesia in Parkinson's disease completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-09-16Clinical Trial Update: Open-Label Safety Study of ADS-5102 in PD Patients With LID [Phase 3]
Open-label safety study of ADS-5102 in Parkinson's disease patients with levodopa-induced dyskinesia completed; results posted.
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease [Phase 2]
A Phase 2 trial evaluating topiramate as an adjunct to amantadine for dyskinesia in Parkinson's disease was terminated; results posted in 20…
-
CLINICAL_TRIALS trial_result · 2018-04-02Clinical Trial Update: Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia [Phase 3]
Phase 3 trial of sarizotan in Parkinson's disease patients with treatment-related dyskinesia completed, with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-02-06Clinical Trial Update: ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study) [Phase 3]
Phase 3 trial update for ADS-5102 (amantadine) in levodopa-induced dyskinesia shows completed study with posted results in 2018.
-
CLINICAL_TRIALS trial_result · 2018-01-10Clinical Trial Update: Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia [Phase 3]
Phase 3 trial evaluating ADS-5102 for dyskinesia in Parkinson's disease patients treated with levodopa has completed and results were posted…
-
CLINICAL_TRIALS trial_result · 2017-01-23Clinical Trial Update: Sarizotan in Parkinson Patients With L-dopa-induced Dyskinesia [Phase 2]
Phase 2 trial update of sarizotan for L-dopa-induced dyskinesia in Parkinson's disease; the study has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: Study of Preladenant for the Treatment of Antipsychotic Induced Movement Disorders in Participants With Schizophrenia (Study P04628) [Phase 2]
Phase 2 clinical trial of preladenant for antipsychotic-induced movement disorders in schizophrenia has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-04-22Clinical Trial Update: A Study of Efficacy and Safety of Eltoprazine HCl for Treating Levodopa-induced Dyskinesia in Parkinson's Disease Patients [Phase 2]
A Phase 2 study evaluating the efficacy and safety of eltoprazine HCl for levodopa-induced dyskinesia in Parkinson's disease; the update ind…
-
CLINICAL_TRIALS trial_result · 2014-11-26Clinical Trial Update: Developing Objective Measures of Levodopa Induced Dyskinesia: (Study 1)
A VA-sponsored study (Study 1) completed and posted results on developing objective measures for Levodopa-induced dyskinesia in Parkinson's …
-
CLINICAL_TRIALS trial_result · 2013-06-06Clinical Trial Update: Movement Disorders Caused by Antipsychotic Drugs in Older Patients [Phase 1]
A Phase 1 trial sponsored by the University of California, San Diego evaluated movement disorders associated with antipsychotic drugs in old…
-
CLINICAL_TRIALS trial_result · 2012-06-29Clinical Trial Update: Capturing Parkinson's Disease Medication Side Effects During Daily Activities
A completed clinical trial update from Great Lakes NeuroTechnologies focused on capturing Parkinson's disease medication side effects during…
-
CLINICAL_TRIALS trial_result · 2011-04-13Clinical Trial Update: Effects of Talampanel on Patients With Advanced Parkinson's Disease [Phase 1, Phase 2]
Talampanel was studied in patients with advanced Parkinson's disease and dyskinesias in a Phase 1/2 trial that has completed.
-
CLINICAL_TRIALS trial_result · 2009-04-27Clinical Trial Update: Different Dyskinesias in Parkinson's Disease and Their Relation to Levodopa Pharmacokinetics [Phase 4]
A completed Phase 4 trial examining different forms of dyskinesia in Parkinson's disease and their relationship to levodopa pharmacokinetics…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Study of LY300164 for the Treatment of Parkinson's Disease [Phase 2]
Phase 2 study of LY300164 for Parkinson disease has completed.